ANGLE Technology is a leading biotechnology company based in Vienna, VA, specializing in the development of innovative solutions for cancer diagnosis and treatment. Their flagship product, the Parsortix PC1 system, is the first medical device to receive FDA clearance for the harvest of intact circulating tumor cells (CTCs), revolutionizing cancer diagnosis and prognosis. With a compact, automated, and easy-to-use design, the Parsortix PC1 system brings the power of CTC analysis into clinical laboratories, providing accurate and efficient results.
In addition to their cutting-edge technology, ANGLE Technology offers laboratory services for biopharmaceutical and translational research, providing a complete CTC harvesting and analysis service. Their GCP-compliant laboratory, staffed by expert professionals, supports research projects globally, eliminating the need for capital equipment and operator training. With a focus on precision medicine, ANGLE Technology is dedicated to making a significant impact in the field of cancer research and treatment.
Generated from the website